Literature DB >> 25753635

In vitro activities of hexaazatrinaphthylenes against Leishmania spp.

Atteneri López-Arencibia1, Daniel García-Velázquez2, Carmen M Martín-Navarro3, Ines Sifaoui4, María Reyes-Batlle3, Jacob Lorenzo-Morales3, Ángel Gutiérrez-Ravelo2, José E Piñero3.   

Abstract

The in vitro activity of a novel group of compounds, hexaazatrinaphthylene derivatives, against two species of Leishmania is described in this study. These compounds showed a significant dose-dependent inhibition effect on the proliferation of the parasites, with 50% inhibitory concentrations (IC(50)s) ranging from 1.23 to 25.05 μM against the promastigote stage and 0.5 to 0.7 μM against intracellular amastigotes. Also, a cytotoxicity assay was carried out to in order to evaluate the possible toxic effects of these compounds. Moreover, different assays were performed to determine the type of cell death induced after incubation with these compounds. The obtained results highlight the potential use of hexaazatrinaphthylene derivatives against Leishmania species, and further studies should be undertaken to establish them as novel leishmanicidal therapeutic agents.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25753635      PMCID: PMC4394827          DOI: 10.1128/AAC.00226-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Drug combinations for visceral leishmaniasis.

Authors:  Piero L Olliaro
Journal:  Curr Opin Infect Dis       Date:  2010-12       Impact factor: 4.915

Review 2.  Protozoan parasites: programmed cell death as a mechanism of parasitism.

Authors:  Iris Bruchhaus; Thomas Roeder; Annika Rennenberg; Volker T Heussler
Journal:  Trends Parasitol       Date:  2007-06-27

Review 3.  Visceral leishmaniasis control: a public health perspective.

Authors:  M Boelaert; B Criel; J Leeuwenburg; W Van Damme; D Le Ray; P Van der Stuyft
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

4.  Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy.

Authors:  Melissa Heffler; Vita M Golubovskaya; Kelli M Bullard Dunn; William Cance
Journal:  Cancer Biol Ther       Date:  2013-06-03       Impact factor: 4.742

5.  In vitro effects of triterpenic acids from olive leaf extracts on the mitochondrial membrane potential of promastigote stage of Leishmania spp.

Authors:  Ines Sifaoui; Atteneri López-Arencibia; Carmen Maria Martín-Navarro; Juan Carlos Ticona; María Reyes-Batlle; Mondher Mejri; Antonio Ignacio Jiménez; Isabel Lopez-Bazzocchi; Basilio Valladares; Jacob Lorenzo-Morales; Manef Abderabba; José E Piñero
Journal:  Phytomedicine       Date:  2014-09-17       Impact factor: 5.340

Review 6.  Cutaneous leishmaniasis.

Authors:  Richard Reithinger; Jean-Claude Dujardin; Hechmi Louzir; Claude Pirmez; Bruce Alexander; Simon Brooker
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

8.  In vivo toxicity, metabolism and pharmacokinetic properties of FAK inhibitor 14 or Y15 (1, 2, 4, 5-benzenetetramine tetrahydrochloride).

Authors:  Vita Golubovskaya; Leslie Curtin; Adrienne Groman; Sandra Sexton; William G Cance
Journal:  Arch Toxicol       Date:  2014-06-12       Impact factor: 5.153

9.  Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry Stewart; Carl Nyberg; Angelica Trujillo; William G Cance; Vita M Golubovskaya
Journal:  Cell Cycle       Date:  2010-03-14       Impact factor: 4.534

10.  FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics.

Authors:  Shalana O'Brien; Vita M Golubovskaya; Jeffrey Conroy; Song Liu; Dan Wang; Biao Liu; William G Cance
Journal:  Oncotarget       Date:  2014-09-15
View more
  7 in total

1.  Leishmanicidal activity of α-bisabolol from Tunisian chamomile essential oil.

Authors:  Soumaya Hajaji; Ines Sifaoui; Atteneri López-Arencibia; María Reyes-Batlle; Ignacio A Jiménez; Isabel L Bazzocchi; Basilio Valladares; Hafidh Akkari; Jacob Lorenzo-Morales; José E Piñero
Journal:  Parasitol Res       Date:  2018-06-28       Impact factor: 2.289

2.  Perifosine Mechanisms of Action in Leishmania Species.

Authors:  Atteneri López-Arencibia; Carmen Martín-Navarro; Ines Sifaoui; María Reyes-Batlle; Carolina Wagner; Jacob Lorenzo-Morales; Sutherland K Maciver; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Metalloprotease Gp63-Targeting Novel Glycoside Exhibits Potential Antileishmanial Activity.

Authors:  Amrita Chakrabarti; Chintam Narayana; Nishant Joshi; Swati Garg; Lalit C Garg; Anand Ranganathan; Ram Sagar; Soumya Pati; Shailja Singh
Journal:  Front Cell Infect Microbiol       Date:  2022-05-04       Impact factor: 6.073

4.  Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species.

Authors:  Verônica da Silva Cardoso; Alane Beatriz Vermelho; Eduardo Ricci Junior; Igor Almeida Rodrigues; Ana Maria Mazotto; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

5.  Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts.

Authors:  Ines Sifaoui; Atteneri López-Arencibia; Carmen Mª Martín-Navarro; María Reyes-Batlle; Carolina Wagner; Olfa Chiboub; Mondher Mejri; Basilio Valladares; Manef Abderrabba; José E Piñero; Jacob Lorenzo-Morales
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

6.  Withanolides from Withania aristata as Antikinetoplastid Agents through Induction of Programmed Cell Death.

Authors:  Atteneri López-Arencibia; Desirée San Nicolás-Hernández; Carlos J Bethencourt-Estrella; Ines Sifaoui; María Reyes-Batlle; Rubén L Rodríguez-Expósito; Aitor Rizo-Liendo; Jacob Lorenzo-Morales; Isabel L Bazzocchi; José E Piñero; Ignacio A Jiménez
Journal:  Pathogens       Date:  2019-10-01

7.  Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box.

Authors:  Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Jacob Lorenzo-Morales; José E Piñero
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.